The development of a strategy for
imaging of glutathione (GSH)
and apurinic/apyrimidinic endonuclease 1 (APE1) in an organism remains
challenging despite their significance in elaborating the correlated
pathophysiological processes. Therefore, in this study, we propose
a DNA-based AND-gated nanosensor for fluorescence imaging of the GSH
as well as APE1 in living cells, animals, and organoids. The DNA probe
is composed of a G-strand and A-strand. The disulfide bond in the
G-strand is cleaved through a GSH redox reaction, and the hybridization
stability between the G-strand and A-strand is decreased, leading
to a conformational change of the A-strand. In the presence of APE1,
the apurinic/apyrimidinic (AP) site in the A-strand is digested, producing
a fluorescence signal for the correlated imaging of GSH and APE1.
This nanosensor enables monitoring of the expression level change
of GSH and APE1 in cells. Additionally, we illustrate the capability
of this “dual-keys-and-locked” conceptual methodology
in achieving specific tumor imaging when GSH and APE1 are present
simultaneously (overexpressed GSH and APE1 in tumor cells) with improving
tumor-to-normal tissue ratio in vivo. Furthermore, using this nanosensor,
the GSH and APE1 also are visualized in organoids that recapitulate
the phenotypic and functional traits of the original biological specimens.
Overall, this study demonstrates the potential of our proposed biosensing
technology in investigating the roles of various biological molecules
involved in specific diseases.